Adalta Capital Management LLC Syros Pharmaceuticals, Inc. Transaction History

Adalta Capital Management LLC

  • $166 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 15, 2019
SELL
$5.55 - $11.34 $88,383 - $180,589
-15,925 Closed
0 $0
Q2 2018

Aug 15, 2018
BUY
$10.16 - $13.65 $7,874 - $10,578
775 Added 5.12%
15,925 $163,000
Q1 2018

May 16, 2018
BUY
$9.47 - $12.98 $35,701 - $48,934
3,770 Added 33.13%
15,150 $197,000
Q4 2017

Feb 14, 2018
BUY
$8.45 - $17.48 $96,160 - $198,922
11,380
11,380 $111,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Adalta Capital Management LLC Portfolio

Follow Adalta Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adalta Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adalta Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email